Multiple Weekly Dalbavancin Dosing for the Treatment of Native Vertebral Osteomyelitis Caused by Methicillin-Resistant Staphylococcus Aureus: A Case Report-Reference-Cited by-同舟云学术

Multiple Weekly Dalbavancin Dosing for the Treatment of Native Vertebral Osteomyelitis Caused by Methicillin-Resistant Staphylococcus Aureus: A Case Report

Published:2017-12-09 Issue: Volume:18 Page:1315-1319
ISSN:1941-5923
Container-title:American Journal of Case Reports
language:en
Short-container-title:Am J Case Rep

Author:

Almangour Thamer A.¹,Fletcher Valerie²,Alessa Mohammed³,Alhifany Abdullah A.⁴,Tabb Deanne⁵

Affiliation:

1. Department of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC, USA

2. Infectious Diseases Physician, Columbus, USA

3. College of Pharmacy, King Saud bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia

4. Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, USA

5. Department of Infectious Diseases Pharmacy, Midtown Medical Center, Columbus Regional Health, Columbus, USA

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dalbavancin as a Viable Alternative for Addressing Treatment Adherence in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: A Case Report;Cureus;2024-02-12

2. Dalba Got Back? Use of Dalbavancin for the Treatment of Vertebral Osteomyelitis;Open Forum Infectious Diseases;2024-02-07

3. A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections;Antibiotics;2023-09-28

4. Dalbavancin in Bone and Joint Infections: A Systematic Review;Pharmaceuticals;2023-07-15

5. Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria;International Journal of Antimicrobial Agents;2023-05